FETAL MATURATION IN A MODEL SYSTEM
模型系统中的胎儿成熟
基本信息
- 批准号:2714061
- 负责人:
- 金额:$ 12.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-07-20 至 1999-05-31
- 项目状态:已结题
- 来源:
- 关键词:baboons bronchopulmonary dysplasia combination chemotherapy cooperative study corticosteroids disease /disorder model embryo /fetus chemotherapy growth /development hormone receptor hormone therapy lipid metabolism nonhuman therapy evaluation premature infant animal protein metabolism pulmonary surfactants respiratory function thyroxine ultrasound
项目摘要
This is a proposal to evaluate new clinically relevant strategies to
improve postnatal outcome of the preterm. The goal is to test the
efficacy and safety of potential maturational agents given 24 hr. before
preterm delivery of baboons at 125 days gestational age, a point in
gestation that will just permit survival with the combined use of
surfactant therapy and intensive care. The treatment interval of 24 hr.
and the gestational age at delivery are selected based on information
being collected using a preterm sheep model funded separately and are
selected to focus the studies on the questions most relevant to treatment
of humans at risk of preterm labor. The fetal baboons will initially be
treated with a single dose of intramuscular betamethasone using fetal
ultrasound to direct the injections. The initial experiment will permit
the selection of a corticosteroid dose using physiologic measures of
efficacy over 24 hr. after delivery followed by measurements of
corticosteroid effects in a variety of tissues. T(4) then will be
evaluated when used in conjunction with corticosteroids. We then will
perform 10 day postnatal studies of animals treated with the
corticosteroid alone, corticosteroid plus T4 and a control group. These
studies will be followed in later years by evaluations of other effector
molecules as well as by changes in the timing of delivery after fetal
treatment. Following fetal treatment and preterm delivery, each newborn
will be extensively studied in terms of performance as a newborn by
evaluating lung function, cardiovascular performance, neuroendocrine
adaptation and kidney function. Tissues then will be collected for
focused studies of effects of the fetal treatments. Lung tissue will be
used to evaluate selected aspects of surfactant lipid and protein
metabolism. Kidney tissue will be used to evaluate receptor systems and
Na+K+ATPase activity. Plasma samples will be processed for hormone
levels, for provocative tests of the thyroid axis and the adrenal axis,
and tissues will be collected for measurements of receptor systems. The
experimental goal is to combine physiologic with biochemical and molecular
indicators of maturation for a number of organ systems to characterize how
the fetus will perform as a newborn and what changes occur as a result of
the fetal therapy.
这是一项评估新的临床相关策略的建议,
改善早产儿的产后结局。 目标是测试
前24小时给予的潜在成熟剂的有效性和安全性
狒狒在胎龄125天时早产,
妊娠期,将允许生存与结合使用
表面活性剂治疗和重症监护。 治疗间隔为24小时。
和分娩时的胎龄是基于信息选择的
使用单独资助的早产绵羊模型收集,
选择的目的是将研究重点放在与治疗最相关的问题上
有早产风险的人。 胎儿狒狒最初会
用单剂量的肌内注射倍他米松治疗,
超声波引导注射 最初的实验将允许
皮质类固醇剂量的选择使用生理测量,
分娩后24小时内的疗效,随后测量
皮质类固醇在各种组织中的作用。 T(4)则为
与皮质类固醇联合使用时进行评价。 然后我们将
对用以下药物处理的动物进行10天产后研究
单独皮质类固醇、皮质类固醇加T4和对照组。 这些
研究将在以后的几年中进行其他效应物的评价。
分子以及胎儿出生后分娩时间的变化
治疗 在胎儿治疗和早产后,每个新生儿
将被广泛研究的表现作为一个新生儿,
评估肺功能、心血管性能、神经内分泌
适应和肾功能。 然后收集组织,
对胎儿治疗效果的集中研究。 肺部组织将
用于评价表面活性剂脂质和蛋白质的选定方面
新陈代谢. 肾组织将用于评估受体系统,
Na+K+ ATP酶活性。 将对血浆样本进行激素处理
水平,对于甲状腺轴和肾上腺轴的激发性测试,
并收集组织用于受体系统的测量。 的
实验目标是将生理学、生物化学和分子生物学联合收割机结合起来
一些器官系统的成熟指标,以表征如何
胎儿作为新生儿的表现以及由于出生而发生的变化
胎儿治疗
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Surfactant phosphatidylcholine half-life and pool size measurements in premature baboons developing bronchopulmonary dysplasia.
患有支气管肺发育不良的早产狒狒的表面活性剂磷脂酰胆碱半衰期和池大小测量。
- DOI:10.1203/00006450-200211000-00019
- 发表时间:2002
- 期刊:
- 影响因子:3.6
- 作者:Janssen,DaphneJMT;Carnielli,VirgilioP;Cogo,PaolaE;Seidner,StevenR;Luijendijk,IngridHI;Wattimena,JLDarcos;Jobe,AlanH;Zimmermann,LucJI
- 通讯作者:Zimmermann,LucJI
Abnormal surfactant metabolism and function in preterm ventilated baboons.
早产通气狒狒的表面活性剂代谢和功能异常。
- DOI:10.1164/ajrccm.158.6.9804128
- 发表时间:1998
- 期刊:
- 影响因子:24.7
- 作者:Seidner,SR;Jobe,AH;Coalson,JJ;Ikegami,M
- 通讯作者:Ikegami,M
Adrenal and thyroid axis function in preterm ventilated baboons.
早产通气狒狒的肾上腺和甲状腺轴功能。
- DOI:10.1159/000068922
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Jobe,AlanH;Scott,SusanM;Polk,DanielH;Seidner,StevenR
- 通讯作者:Seidner,StevenR
Prenatal glucocorticoid exposure and postnatal adaptation in premature newborn baboons ventilated for six days.
通气六天的早产新生狒狒的产前糖皮质激素暴露和产后适应。
- DOI:10.1016/j.ajog.2004.04.010
- 发表时间:2004
- 期刊:
- 影响因子:9.8
- 作者:Smith,LynneM;Altamirano,AKimberly;Ervin,MGore;Seidner,StevenR;Jobe,AlanH
- 通讯作者:Jobe,AlanH
Metabolism of endogenous surfactant in premature baboons and effect of prenatal corticosteroids.
早产狒狒内源性表面活性剂的代谢及产前皮质类固醇的作用。
- DOI:10.1164/ajrccm.160.5.9808070
- 发表时间:1999
- 期刊:
- 影响因子:0
- 作者:Bunt,JE;Carnielli,VP;Seidner,SR;Ikegami,M;DarcosWattimena,JL;Sauer,PJ;Jobe,AH;Zimmermann,LJ
- 通讯作者:Zimmermann,LJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALAN H JOBE其他文献
ALAN H JOBE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALAN H JOBE', 18)}}的其他基金
Initiation and Progression of Preterm Lung Injury with Ventilation
通气引起早产肺损伤的发生和进展
- 批准号:
8333719 - 财政年份:2012
- 资助金额:
$ 12.98万 - 项目类别:
Initiation and Progression of Preterm Lung Injury with Ventilation
通气引起早产肺损伤的发生和进展
- 批准号:
8675892 - 财政年份:2012
- 资助金额:
$ 12.98万 - 项目类别:
Initiation and Progression of Preterm Lung Injury with Ventilation
通气引起早产肺损伤的发生和进展
- 批准号:
9060755 - 财政年份:2012
- 资助金额:
$ 12.98万 - 项目类别:
Initiation and Progression of Preterm Lung Injury with Ventilation
通气引起早产肺损伤的发生和进展
- 批准号:
8517784 - 财政年份:2012
- 资助金额:
$ 12.98万 - 项目类别:
Late Preterm Birth, Ureaplasma Species and Childhood Lung Disease
晚期早产、解脲支原体和儿童肺病
- 批准号:
7713829 - 财政年份:2009
- 资助金额:
$ 12.98万 - 项目类别:
Late Preterm Birth, Ureaplasma Species and Childhood Lung Disease
晚期早产、解脲支原体和儿童肺病
- 批准号:
7938669 - 财政年份:2009
- 资助金额:
$ 12.98万 - 项目类别:
Late Preterm Birth, Ureaplasma Species and Childhood Lung Disease
晚期早产、解脲支原体和儿童肺病
- 批准号:
8304364 - 财政年份:2009
- 资助金额:
$ 12.98万 - 项目类别:
Late Preterm Birth, Ureaplasma Species and Childhood Lung Disease
晚期早产、解脲支原体和儿童肺病
- 批准号:
8112493 - 财政年份:2009
- 资助金额:
$ 12.98万 - 项目类别:
相似海外基金
Metabolic mechanisms underlying bronchopulmonary dysplasia-associated pulmonary hypertension
支气管肺发育不良相关肺动脉高压的代谢机制
- 批准号:
10736803 - 财政年份:2023
- 资助金额:
$ 12.98万 - 项目类别:
The Role of Outpatient Diuretic Therapy in Bronchopulmonary Dysplasia
门诊利尿疗法在支气管肺发育不良中的作用
- 批准号:
10663469 - 财政年份:2023
- 资助金额:
$ 12.98万 - 项目类别:
Basic research for the development of therapies for bronchopulmonary dysplasia focusing on the IL-33 pathway.
以 IL-33 通路为重点的支气管肺发育不良疗法开发的基础研究。
- 批准号:
23K07250 - 财政年份:2023
- 资助金额:
$ 12.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Salivary miRNAs as Prognostic Markers of Pulmonary Hypertension Associated with Bronchopulmonary Dysplasia in Extremely Low Gestational Age Infants
唾液 miRNA 作为极低胎龄婴儿支气管肺发育不良相关肺动脉高压的预后标志物
- 批准号:
10739639 - 财政年份:2023
- 资助金额:
$ 12.98万 - 项目类别:
Novel Small Molecule Drug Candidate for the Prevention of Bronchopulmonary Dysplasia
预防支气管肺发育不良的新型小分子候选药物
- 批准号:
10698418 - 财政年份:2023
- 资助金额:
$ 12.98万 - 项目类别:
DLL4 in the Developing Lung and Bronchopulmonary Dysplasia (BPD)
DLL4 在发育中的肺和支气管肺发育不良 (BPD) 中的作用
- 批准号:
10584811 - 财政年份:2023
- 资助金额:
$ 12.98万 - 项目类别:
A novel approach for prevention of Bronchopulmonary dysplasia in at-risk pre-term infants
预防高危早产儿支气管肺发育不良的新方法
- 批准号:
10765750 - 财政年份:2023
- 资助金额:
$ 12.98万 - 项目类别:
A novel approach for prevention of Bronchopulmonary dysplasia in at-risk pre-term infants
预防高危早产儿支气管肺发育不良的新方法
- 批准号:
10482142 - 财政年份:2022
- 资助金额:
$ 12.98万 - 项目类别:
The role of IL-33 in hyperoxia-induced neonatal lung injury and bronchopulmonary dysplasia
IL-33在高氧诱导的新生儿肺损伤和支气管肺发育不良中的作用
- 批准号:
10593394 - 财政年份:2022
- 资助金额:
$ 12.98万 - 项目类别:
The role of IL-33 in hyperoxia-induced neonatal lung injury and bronchopulmonary dysplasia
IL-33在高氧诱导的新生儿肺损伤和支气管肺发育不良中的作用
- 批准号:
10665809 - 财政年份:2022
- 资助金额:
$ 12.98万 - 项目类别:














{{item.name}}会员




